BlackRock, Inc. 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Caribou Biosciences, Inc. CRBU |
BlackRock Inc. BLK |
6,281,683 6.800% |
-786,785 (-11.13%) |
Filing |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
BlackRock Inc. BLK |
7,068,468 8.000% |
2,346,385 (+49.69%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
BlackRock Inc. BLK |
4,722,083 7.700% |
4,722,083 (New Position) |
Filing |